| Year | 2023 | 2022 |
|---|---|---|
| CF from Operating Activities | 2.57B | 3.56B |
| Net Income | 5.51B | 8.24B |
| Depreciation & Amortization | 622.8M | 1.06B |
| Deferred Income Taxes | 0 | 0 |
| Stock Based Compensation | 144.5M | 127M |
| Change in Working Capital | -2.46B | -344.9M |
| Accounts Receivable | -365.1M | -102M |
| Inventory | -160M | 218.5M |
| Accounts Payable | -502M | -381.1M |
| Other Working Capital | -1.43B | -80.3M |
| Other Non-Cash Items | -1.25B | -5.52B |
| CF from Investing Activities | 2.57B | 3.56B |
| Investments in Property, Plant & Equipment | -189.3M | -649.8M |
| Net Acquisitions | 0 | 1.8B |
| Investment Purchases | 0 | -2.29B |
| Sales/Maturities of Investments | 0 | 2.29B |
| Other Investing Activites | 726.3M | -1.52B |
| CF from Financing Activities | -2.35B | -3.46B |
| Debt Repayment | 0 | -352M |
| Common Stock Issued | 0 | 0 |
| Common Stock Repurchased | 0 | 0 |
| Dividends Paid | -1.83B | -2.97B |
| Other Financing Activites | -517.1M | -133.8M |
| Free Cash Flow | 2.38B | 2.91B |
| Operating Cash Flow | 2.57B | 3.56B |
| Capital Expenditures | -189.3M | -649.8M |
| Cash at Beginning of Period | 366M | 627.6M |
| Cash at End of Period | 1.12B | 366M |
| Net Change In Cash | 754M | -261.6M |
Pfizer Limited
PFIZER.NS
NSE
4080.25INR45.35 (1.12%)
PFIZER.NS Financial Statements
Retained Earning Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Retained Earnings (Previous Year) | 14.6B | 11.33B |
| Net Income | 5.51B | 6.24B |
| Stock Repurchases | 0 | 0 |
| Dividend Paid | -1.83B | -2.97B |
| Retained Earnings | 18.28B | 14.6B |
| Other Distributions | 1.85B | 293.7M |
PPE Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Gross PPE | 1.52B | 1.85B |
| Annual Depreciation | 622.8M | 1.04B |
| Capital Expenditure | -189.3M | -649.8M |
| Net PPE | 1.08B | 1.46B |
Intangible and Goodwill Schedule
| Year | 2023 | 2022 |
|---|---|---|
| Acquisitions and Adjustments | 0 | 0 |
| Goodwill (Previous Year) | 5.27B | 5.27B |
| Goodwill | 5.27B | 5.27B |